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Abstract
The toxicity of Loxosceles spider venom has been attributed to a rare enzyme, sphingomyelinase D, which transforms
sphingomyelin to ceramide-1-phosphate. The bases of its inflammatory and dermonecrotic activity, however, remain
unclear. In this work the effects of ceramide-1-phosphate on model membranes were studied both by in situ generation of
this lipid using a recombinant sphingomyelinase D from the spider Loxosceles laeta and by pre-mixing it with sphingomyelin
and cholesterol. The systems of choice were large unilamellar vesicles for bulk studies (enzyme kinetics, fluorescence
spectroscopy and dynamic light scattering) and giant unilamellar vesicles for fluorescence microscopy examination using a
variety of fluorescent probes. The influence of membrane lateral structure on the kinetics of enzyme activity and the
consequences of enzyme activity on the structure of target membranes containing sphingomyelin were examined. The
findings indicate that: 1) ceramide-1-phosphate (particularly lauroyl ceramide-1-phosphate) can be incorporated into
sphingomyelin bilayers in a concentration-dependent manner and generates coexistence of liquid disordered/solid ordered
domains, 2) the activity of sphingomyelinase D is clearly influenced by the supramolecular organization of its substrate in
membranes and, 3) in situ ceramide-1-phosphate generation by enzymatic activity profoundly alters the lateral structure
and morphology of the target membranes.
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Introduction
Spiders of the genus Loxosceles are considered of medical
importance because they are capable of causing severe local and
occasionally systemic envenomation in humans [1–3]. The venom
of Loxosceles spiders contains an unusual enzyme responsible for the
dermonecrotic local lesions characteristic of the envenomation
syndrome (cutaneous loxoscelism) and its rarer but more severe
systemic effects [4–6]. An extensive biochemical characterization
of this enzyme is that of Lee and Lynch [7], who established that it
is a phospholipase which can hydrolyze sphingomyelin (SM) as
well as an array of lysoglycerophospholipids with various polar
head groups, but not double chain glycerophospholipids or
sphingosylphosphorylcholine. The enzyme has been often referred
to as sphingomyelinase D (SMase D, SMD) or, as Lee and Lynch
suggested, phospholipase D by virtue of its wider spectrum of lipid
substrates. Since this study deals with the effects of the action of
this enzyme on model sphingomyelin- containing membrane
systems, we will refer to it as SMD. When acting on SM, the
enzyme releases choline and ceramide-1-phosphate (Cer-1-P).
Although it is reasonable to suppose that other venom components
can influence the outcome of envenomation, it has been
convincingly demonstrated that SMD is both necessary and
sufficient to elicit the characteristic dermonecrotic lesions [8],
which typically follow a massive inflammatory response that has by
now a well described natural history [9]. Morphological changes
[10] and increased susceptibility to complement-mediated hemo-
lysis of red blood cells resulting from SMD action have been
reported [11], demonstrating that SM is available for enzymatic
action. van Meeteren et al. have argued that the lysophospholipase
activity of the enzyme on circulating lysophospholipids underlies
the inflammatory and dermonecrotic effects of the venom [12] and
find a role for the sphingomyelinase D activity unlikely [13].
Dragulev et al., however, have shown that recombinant SMD by
itself can elicit production of proinflammatory factors in the
absence of any source of exogenous lysophospholipids [14]. The
latter favor the idea that the sphingomyelinase D activity of the
enzyme is important in its overall toxicity with the implication that
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leads to the clinical manifestations. These proposals are not
mutually exclusive [15] and SMD has been recently suggested as a
useful new probe in the study of the effects of SM metabolism at
the cellular level [16].
Over the last decade an increasing amount of study has been
devoted to the physicochemical characterization of sphingolipids,
their metabolism and involvement in an important number of
cellular processes [17–19]. Although sphingomyelins are very
abundant in many cellular membranes, the level of the simple
phosphosphingolipid Cer-1-P is very low [20]. In mammalian cells
Cer-1-P is synthesized by ceramide kinase from ceramide (Cer)
and hydrolyzed to ceramide by a ceramide-1-phosphatase activity.
Its low abundance, coupled to by now well established synthetic
and degradative pathways, have led to the proposal that Cer-1-P
levels are tightly regulated and that this simplest of phospho-
sphingolipids is an important signaling molecule [21]; fluctuations
in Cer-1-P levels have been associated to a number of cellular
processes such as phagocytosis [18], ion channel activity [22],
inflammation [23], cell survival and tumorigenesis [24,25].
Although the exact role of sphingolipids in these phenomena
remains to be established two general views, not necessarily
exclusive, are espoused: in one, sphingolipids are viewed as second
messengers responsible for triggering the action of effectors
but without a direct role as lipid species within distinct lipid
supramolecular assemblies; in another view, their accumulation
confers particular supramolecular properties to the membranes
in which they are incorporated (permeability, lateral organiza-
tion in terms of packing and/or curvature) in ways that elicit
cellular responses by local environmental changes [26]. Dis-
tinguishing between these possibilities is not a trivial task, as a
description of the effects of supramolecular lipid structure on
cellular activities requires a general understanding of how lipid
supramolecular/interfacial properties impinge on a wide array
of cellular processes. In the particular case of Cer-1-P, a more
specific understanding of the properties of membranes contain-
ing this lipid is required. Basic aspects of the membrane
organization and ionization behavior of palmitoyl Cer-1-P,
both pure and mixed with selected glycerophospholipids,
have been described [27]. This article shows that the main
transition temperature of Cer-1-P is considerably higher than
that of its parent SM but, unlike ceramide or the structurally
similar lysophosphatidic acid, pure Cer-1-P is capable of
forming lamellar phases. Somewhat paradoxically, Cer-1-P
can induce negative curvature at low concentrations and
destabilize lamellar phases of particular glycerophospholipids
[27].
The general goal of this study was to establish whether SMD
activity could cause gross changes in the supramolecular properties
of SM-containing membranes. To this end, the study was divided
into three parts. The first focused on the effects of Cer-1-P on the
supramolecular organization of SM-based model membranes
under equilibrium conditions (i.e. in the absence of enzyme).
Second, the effects of substrate supramolecular structure and
composition on SMD activity were addressed. Finally, some
structural/morphological effects resulting from the accumulation
of Cer-1-P by SMD action in model membranes were character-
ized. The kinetics of SMD activity were studied using SM
substrates with different states of organization, such as micelles and
unilamellar vesicles. Structural changes in SM-containing large
and giant unilamellar vesicles upon enzymatic action were also
studied by a variety of optical methods.
Materials and Methods
Lipids and reagents
N-lauroyl-D-erythro-sphingosylphosphorylcholine (C12SM), egg
sphingomyelin (egg SM, 86% N-hexadecanoyl-D-erythro-sphingo-
sylphosphorylcholine), N-lauroyl-ceramide-1-phosphate (C12Cer-
1-P), N-palmitoyl-ceramide-1-phosphate (C16Cer-1-P), 1,2-dio-
leoyl-sn-glycero-3-phosphocholine (DOPC), 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC), 1-lauroyl-2-hydroxy-sn-gly-
cero-3-phosphocholine (C12LPC) and cholesterol, where pur-
chased from Avanti Polar Lipids (Alabaster, AL, USA). Unless
specified otherwise, all lipids were in dry powder form and were
used without further purification. After dissolving to either 10 mM
in chloroform (C12 and egg SM) or chloroform:methanol:water
(80:20:2 v/v/v, C12 and C16Cer-1-P) lipid concentration was
determined by phosphorus analysis [28,29]. The fluorescent
probes 1,19-dioctadecyl-3,3,39,39-tetramethylindocarbocyanine
perchlorate (DiIC18) and 6-dodecanoyl-2-dimethylaminonaphtha-
lene (LAURDAN) were from Invitrogen (Molecular Probes,
Copenhagen, Denmark). Atto647-conjugated 1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine (Atto647-DPPE) was from Atto-
Tec, Siegen, Germany. All general reagents (Triton X-100,
solvents, buffers and salts) were from Sigma-Aldrich (Copenhagen,
Denmark).
Differential scanning calorimetry (DSC)
Suspensions of 2 or 5 mM C12SM, C12Cer-1-P, egg SM,
C16Cer-1-P were prepared by hydration of dry lipid films in
phosphate buffered saline (PBS), 2 mM MgCl2, pH 7.4, by
vortexing for 90 minutes at 75uC. Differential scanning calorim-
etry (DSC) for the C12SM was performed using a Calorimetric
Sciences Corp. model 4100 MC-DSC (TA Instruments, Lindon,
UT, USA). The samples were allowed to equilibrate and then
scanned from 210 to 85uC with a scan speed of 6 K/hour.
C12Cer-1-P was measured in a TA Instruments NANO- DSC with
a scan rate of 0.5 K/minute. At least 7 scans of each sample were
performed.
Preparation of large unilamellar vesicles (LUVs)
Mixed lipid solutions in chloroform (SM, cholesterol) or
chloroform:methanol:water (80:20:2 v/v/v, for C12Cer-1-P-con-
taining mixtures) were evaporated under a gentle nitrogen stream
and kept under vacuum overnight to remove residual solvent. The
dry lipid films were hydrated in reaction buffer (PBS, 2 mM
MgCl2, pH 7.4) preheated to 55uC. The concentrations were
adjusted to 0.5 mM for SM. For the enzyme kinetic studies all
samples provided equal concentration of substrate (0.25 mM). The
samples were vortexed for 90 minutes at 55uC until all lipid was
dispersed. The dispersions were freeze-thawed 3 times before
extrusion through Whatman 0.1 mm membranes (PC, Track-Etch)
using a mini-extruder from Avanti Polar Lipids (Alabaster, AL,
USA). Vesicle preparations were extruded 18 times at 55uC. Loss
of lipids from extrusion was measured by phosphorus analysis
[28,29] and recovery was always within the error of the technique
(65%). LAURDAN and DiIC18 labeling were at 0.25 mol% of
total lipids by premixing the probes with the lipids before
evaporation. Although pure C12Cer-1-P could be suspended in
aqueous medium preparation of LUVs using this procedure was
unsuccessful.
Preparation of giant unilamellar vesicles (GUVs)
GUVs were generated using previously described procedures of
electroformation in a home-built array of chambers, which contain
two Pt wire electrodes each [30]. First, 0.2 mg/ml solutions of
The Action of Sphingomyelinase D on Membranes
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e36003lipid (mixtures) in chloroform including the fluorescent probe (0.5
mol% respect to total lipids) were deposited on the electrodes
(4 mL per wire). The remaining solvent was evaporated under
vacuum for 30 min. For the electroformation of GUVs in salt-free
environment, a 2 V, 10-Hz alternating electric field was applied
for ca. 90 minutes [31] using a Digimess FG100 function
generator (Vann Draper Electronics, Stenson, Derby, UK). This
preparation was performed in sucrose osmotically matched to the
reaction buffer (either PBS, 2 mM MgCl2, pH 7.4, 286 mOsM, or
Hepes buffered saline). For electroformation of GUVs under
physiological conditions (same buffer supplemented with 50 mM
of sucrose), the following protocol was applied: (a) 5 min at
106 mV, 500 Hz; (b) 20 min at 940 mV, 500 Hz; (c) 90 min at
2.61 V, 500 Hz [32,33]. For electroformation the chambers and
solutions were thermostated to temperatures above the main
transition temperature of the component with the highest main
transition (40uC for C12SM, 45uC for the lipid mixtures).
Afterwards, the solutions containing GUVs were cooled to room
temperature (RT) and removed from the chamber using a pipette.
An aliquot of each sample was diluted (1:4) in the reaction buffer
alone (GUVs prepared without salt) or buffer supplemented with
50 mM of glucose (GUVs prepared in physiological conditions),
added to an 8 well chamber (m-slide, Ibidi, Germany) and allowed
to settle at RT overnight. After this step the GUVs were studied in
the fluorescence microscope. In some of these experiments the
GUVs were immobilized as described in [34]. Preparation of
GUVs for mixtures of C12Cer-1-P/C12SM containing 50 mol% or
more of C12Cer-1-P was unsuccessful using these procedures.
Recombinant enzymes
Expression and purification of recombinant soluble and active
C-terminal His-tagged sphingomyelinase D from Loxosceles laeta,
isoform 2, was done as previously reported [35]. The inactive
isoform Lb3 from Loxosceles boneti used as control was His-tagged at
the N-terminus and expressed following the same protocol as for
the active enzyme. The Lb3 protein was enzymatically inactive.
Protein quantitation was done using the Bicinchoninic acid
reagent (BCA, Thermoscientific, USA) using the protocols and
standards supplied with the reagents. Both proteins were stored at
4uC in stock solutions at 250 mg/ml in PBS buffer. Recombinant
enzyme purity was always greater than 95% by SDS-PAGE and
protein concentration and activity were assayed at regular
intervals.
Assay of sphingomyelinase activity
Enzymatic activity was measured using a cuvette-based coupled
enzymatic assay in the reaction buffer (PBS pH 7.4, 2 mM MgCl2)
in a 1 ml final volume. The assay follows the oxidation of choline
(released by SMD) to betaine by choline oxidase (from Alcaligenes,
Sigma) and the transformation of the Amplex RedH (Invitrogen)
substrate into resorufin by horseradish peroxidase (Sigma) in the
presence of hydrogen peroxide released by choline oxidation.
Resorufin production was followed spectrophotometrically (Perkin
Elmer Lambda 35 UV/VIS spectrometer) by measuring the
absorbance at 570 nm. Briefly, known amounts of recombinant
SMD (ranging from 0.78 to 50 ng/ml) were incubated with a
master mixture such that the final concentration of SM was always
0.25 mM -presented either as mixed micelles (in 0.2% Triton X-
100) or LUVs-, 0.1 U/ml choline oxidase, 1 U/ml horseradish
peroxidase and 0.05 mM Amplex Red. The specific activities of
both choline oxidase and horseradish peroxidase were indepen-
dently calibrated to ensure quantitative detection of choline
production by sphingomyelinase D. Units (U) are always mmoles of
resorufin produced (molar extinction of resorufin
e570=54,000 M
21). Specific activities of SMD on various
substrates were calculated by dividing the U/min during the
linear phase of the reaction by the amount of SMD used in the
assays using at least three different SMD concentrations per
specific activity measurement. The SMD concentrations were
chosen such that the slope of the reactions depended solely on the
concentration of SMD. Each kinetic determination was run in
duplicate and repeated at least twice. The statistical significance of
differences in reaction rates and/or specific activities were
established by pairwise comparisons using Student’s t-test and
globally by ANOVA.
Dynamic light scattering
Dynamic light scattering is a widely used method for
determining an average size or a size distribution of scattering
particles in a suspension. Unlabeled C12SM, C12SM:C12Cer-1-P
and C12SM:cholesterol LUVs were prepared as described above.
Dynamic light scattering experiments were done in a Brookhaven
Instruments goniometer setup (BI-200SM) equipped with a Melles
Griot He-Ne laser, l=632.8 nm. The measurements were
performed at a single scattering angle, 90u, in homodyne detection
mode. Cylindrical glass cuvettes, with an outer diameter of
10 mm, were embedded within an index matching and thermo-
stating bath. The glass cuvettes were autoclaved prior to use. The
sample temperature was maintained at 25uC during the
measurements. The autocorrelation function generated from the
intensity fluctuations was analyzed to obtain the distribution of
particle sizes using two techniques: multiple pass Non-Negative
Least Squares (NNLS) and a regularized NNLS, CONTIN [36].
Fluorescence spectroscopy measurements
All bulk fluorescence measurements were done in quartz
cuvettes in an ISS Chronos spectrofluorometer (ISS, Champaign,
USA) at 22uC. LAURDAN Generalized Polarization (GP) was
measured using a 374 nm LED excitation source and fluorescence
intensity at 440 and 490 nm was collected for GP calculations [37]
(see below). To eliminate scatter a long pass filter cutting below
408 nm was located before the emission monochromator. For the
Fo ¨rster Resonance Energy Transfer (FRET) experiments with
LAURDAN and DiIC18, excitation was as above but emission
collected at 590 nm (the emission maximum of DiIC18). Protein
fluorescence emission spectra (originated mainly by the aromatic
amino acids tryptophan and tyrosine) were obtained using a
280 nm diode excitation source. For protein fluorescence
polarization measurements, a ‘‘L’’ configuration was used. The
excitation polarizer was set at vertical position and the emission
polarizer was rotated from vertical to horizontal position using a
step-motor. Data were collected at 340 nm for 10 minutes for
each sample and the results were expressed as the average of all
values 6 the averaged standard error of the measurements. For
protein fluorescence polarization measurements an additional
bandpass filter (350625 nm) was mounted before the emission
monochromator and short path cuvettes (0.4 cm) were used to
minimize scatter noise of the samples. The statistical significance of
differences were established by pairwise comparisons using
Student’s t-test.
Interpretation of the LAURDAN GP function
The LAURDAN GP is a function of the probe’s emission
spectrum position. The fluorescence emission properties of
LAURDAN are sensitive to the water dipolar relaxation processes
that occur in the environment of the probe [38]. The energy of the
excited state progressively decreases as dipolar relaxation increas-
es, shifting the probe’s emission spectrum to longer wavelengths.
The Action of Sphingomyelinase D on Membranes
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membrane regions (such as the solid-ordered phase in bilayers) is
very low compared to what is observed in less packed regions (such
as the liquid-disordered phase in bilayers) [37,39]. Therefore,
when a solid-ordered to liquid-disordered phase transition occurs
in the membrane, a prominent red shift in the fluorescence
emission spectrum of the probe is observed (from blue to green; an
almost 50 nm shift). The GP function was defined [39]
analogously to the fluorescence polarization function as:
GP~
IB{IR
IBzIR
where IB and IR correspond to the intensities at the blue and red
edges of the emission spectrum (440 and 490 nm) using a given
excitation wavelength. In lipid bilayers high LAURDAN GP
values (0.5–0.6) correspond to laterally ordered phases (e.g solid-
ordered or gel) whereas low LAURDAN GP values (below 0.1)
correspond to liquid-disordered phases [37,39].
Fluorescence correlation spectroscopy (FCS)
C12SM LUVs prepared as described above were labeled with
0.02 mol% of the fluorescent lipid probe Atto647-DPPE. Labeled
liposomes were separated from potentially free fluorophores by
chromatography through a Sephacryl S400 column. For the FCS
measurements, labeled LUVs were diluted 1:100 in unlabeled
C12SM LUVs (final concentration 0.25 mM C12SM). The
measurements were carried out by means of a custom built
multiphoton excitation system constructed in a Nikon Eclipse TI
microscope. The objective used was a 606 water immersion
objective, NA 1.29. The excitation light source was a femtosecond
Ti:Sa laser (HPe Mai Tai DeepSee, tunable excitation range 690–
1040 nm, Spectra Physics, Mountain View, CA) and the
excitation wavelength was 838 nm. The fluorescence signal was
collected using a bandpass BrightLine HC 676/29 nm. All filters
were from AHF Analysetechnik, Germany. The fluorescence was
detected by means of a Hamamatsu H7422P-40 photomultiplier.
The microscope is controlled by SimFCS (Laboratory for
Fluorescence Dynamics, University of California, Irvine, CA,
USA). The FCS data was analyzed using SimFCS and Globals for
Spectroscopy (Laboratory for Fluorescence Dynamics, University
of California, Irvine, CA, USA) using the model of single or two
species diffusing in 3D Gaussian 2-photon excitation volume
detailed in [40,41]. Particularly, the data generated from the
C12SM liposomes was fitted using the model above for two
diffusing species in 3D. Two diffusion coefficients (D1 and D2)
were used for analysis for two reasons: the first is that although the
initial state corresponds to a largely homogeneous LUV
preparation, there are however small heterogeneities present; the
second is that, after enzyme addition, not all vesicles would be
expected to be affected in the same way and in the same time
window. Therefore, for the analysis of the enzymatic effects D1
was fixed and the program allowed generating the best fit by
optimizing the value of the second diffusion cofficient D2.
Diffusion coefficients were used to calculate particle radii using
the Stokes-Einstein relationship [42]. The data for the FCS
measurements was typically collected for 3 min. The experiments
were carried out at 21uC.
Fluorescence microscopy
Fluorescence imaging of DiIC18-labeled GUV preparations was
carried out in an inverted, confocal laser scanning microscope
(Zeiss LSM 510 META NLO, Carl Zeiss, Jena, Germany) at room
temperature. Both 406and 636water-immersion objectives with
a NA of 1.2 were used. DiIC18 was excited at 543 nm, and its
fluorescence signal was collected applying a 560 nm long-pass
filter. The images are contrast-enhanced and the background was
cut-off by image-processing software. LAURDAN GP in GUVs
was measured in the same custom-built, two-photon excitation
microscope used for FCS measurements with a 606NA 1.2 water-
immersion objective. At least 20 individual vesicles were analyzed
from at least two independent preparations. LAURDAN was
excited in the two-photon excitation mode at 780 nm. The
fluorescent signals of the probe’s emission spectrum were split with
a dichroic mirror centered at 470 nm and collected using band-
pass filters of 438612 nm and 494610 nm simultaneously with
two Hamamatsu H7422P-40 photomultipliers. Based on the
acquired intensity images, LAURDAN GP images were computed
with SimFCS software (Laboratory for Fluorescence Dynamics,
Irvine, CA). The GP images were calibrated with a correction
factor G obtained from a LAURDAN GP standard (2 mM
LAURDAN in DMSO) as previously described [43]. The
LAURDAN GP value of the reference solution was measured in
an ISS Chronos spectrofluorometer (ISS, Champaign, USA) as
described above.
Results
Effects of Cer-1-P in pre-mixed SM model membranes
Differential scanning calorimetry experiments show that Cer-1-
P exhibits a much higher main transition temperature than the
parent SM (Fig. 1). In addition, C12Cer1P dispersions show two
endotherms but only one major change around 40uC (from
0.59760.005 at 22uC/30uCt o20.02768610
26 at 50uC) occurs
in the value of the LAURDAN GP similar to that observed at the
main phase transition temperature of pure glycerophospholipids
[39].
Premixing of C12SM with increasing amounts of C12Cer-1-P
decreases the extent of dipolar relaxation in the membranes as
measured by the polarity sensitive LAURDAN probe in lipid
suspensions. LAURDAN GP measurements at 22uC, that is, a
temperature between the main transitions of both lipids, show a
monotonic increase from values corresponding to a liquid
disordered (ld) phase to a more highly packed structure (Fig. 2).
In particular, pure C12Cer-1-P dispersions display a GP value of
0.6 indicating a low degree of solvent dipolar relaxation. In
glycerophospholipids this value corresponds to a solid ordered
phase (so), the so-called gel phase [39].
Examination of this system by fluorescence microscopy using
DiIC18 and LAURDAN provides spatially-resolved data for
interpretation of the behavior of these lipid membranes. When
GUVs are prepared from premixed C12SM and C12Cer-1-P and
examined microscopically at room temperature, the formation of
distinct domains can be visualized by the exclusion of DiIC18
(Fig. 3A). These Cer-1-P-enriched domains are more tightly
packed as revealed by the well known photoselection effect of
LAURDAN [44] observed in the intensity images obtained at the
GUV’s polar region (Fig. 3B) and the local LAURDAN GP
imaging measurements (Fig. 3C) obtained at the equatorial region
of the vesicle. This shows that at 22uC the C12SM:C12Cer-1-P
mixture exhibits so/ld phase coexistence, as reported for binary
mixtures of glycerophospholipids [45,46] and a POPC:C16Cer-1-P
mixture at XCer-1-P.0.3 [47].
Kinetics of SMD activity on C12SM vesicles
The activity of SMD has been often studied using SM as part of
uncharacterized lipid dispersions [7]. In our experiments with
mixed Triton X-100 micelles, the specific activity of the enzyme is
The Action of Sphingomyelinase D on Membranes
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(lauroyl and palmitoyl SM, 119.863.31 and 128.5613.16 mmol/
min per mg SMD, respectively). When we studied these substrates
as part of bilayers, however, the activity of the enzyme is
significantly lower for both substrates. Interestingly, when the
substrate is organized in bilayers, enzyme activity is significantly
different between them, with egg SM (initially in the so phase at the
assay temperature) being processed with 60% lower velocity than
the C12SM (initially in the ld phase) (Fig. 4).
In order to explore the structural consequences of in situ
generation of Cer-1-P in SM containing membranes we
concentrated on C12SM. Dynamic light scattering (DLS) exper-
iments using pure C12SM LUV preparations show that extruded
vesicles cluster around the expected size of ,100 nm, and that this
size distribution is stable for at least 24 hours in the absence of
enzyme (Fig. 5). Addition of SMD causes a progressive increase in
sample polydispersity whose time course depends on the amount
of enzyme added; 50 ng/ml SMD causes a progressive slow
increase in scattering whereas when 1 mg/ml enzyme is added,
scattering exceeds the limits of meaningful size distribution
analysis within an hour. The increase in polydispersity was
apparent when comparing two different methods of computation,
non-negative least squares (NNLS) and CONTIN, which showed
a few punctual differences but overall agreement (P,0.001).
To independently explore the mechanism underlying the DLS
data, we conducted a series of fluorescence experiments. The first
one was a simple assay with unilamellar vesicles independently
labeled with two membrane fluorophores that function as a FRET
pair. LUVs separately labeled with LAURDAN and DiIC18 were
incubated with SMD, excited at 374 nm and the DiIC18 emission
followed. As shown in Fig. 6, there is a marked increase in the
DiIC18 emission at 590 nm over the untreated mixture of vesicles,
indicating an increase in donor-acceptor interaction.
The second experiment consisted of measurements by fluores-
cence correlation spectroscopy (FCS) of C12SM LUVs labeled with
Atto 647-DPPE (approx. 20 molecules per vesicle) mixed with
unlabeled vesicles (cf. Methods). The resulting autocorrelation
curves of the LUV preparation could be fitted by a single diffusion
coefficient, however, a two diffusion component fit proved more
adequate for the data (typical curves are shown in figure 7A). One
of the component’s diffusion coefficients (D1) was found to be
4.660.25 mm
2/s corresponding to a radius of about 44 nm, in
Figure 1. Differential scanning calorimetry of pure sphingomyelins and ceramide-1-phosphates. Thermogram of A) C12SM (green) and
C12Cer-1-P (red). B) Thermogram of egg SM (green) and and C16Cer-1-P (red).
doi:10.1371/journal.pone.0036003.g001
Figure 2. LAURDAN GP of C12SM:C12Cer-1-P mixtures at 226C.
The LAURDAN GP of suspensions of mixed C12SM and C12Cer-1-P at
different ratios was measured. Pure C12Cer-1-P could not be extruded
so the LAURDAN GP measurement was taken directly on the lipid
suspension.
doi:10.1371/journal.pone.0036003.g002
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Addition of the enzyme to the C12SM vesicles had two clear
consequences. First a significant decrease in labeled particle
mobility was observed, i.e. a time-dependent decrease in the
calculated diffusion coefficient (D2) of the second component of the
fit (Fig. 7B). This effect is interpreted as an increase in the particle
size. Second, an important redistribution of the fluorescent probe
became apparent. This is seen as a decrease in the average
intensity of the individual diffusing particles measured in the bulk
of the suspension, with a concomitant sedimentation of bright
microscopic structures to the bottom of the chamber (Figure 8C).
Surprisingly, the number of fast diffusing particles (those
contributing to D1) was not seen to decrease (as indicated by a
decrease of G0 of the autocorrelation curves, which is inversely
proportional to the number of fluorophores in the observation
volume). We interpret this as a consequence of fusion of labeled
and unlabelled vesicles causing dilution of the probe (see Methods).
This effect is not seen in the control measurements without
enzyme. As an additional control measurement, an equal volume
of 0.2% Triton-X100 was added to the mixture of unlabelled and
labelled C12SM LUVs that resulted, as expected, in a homogenous
particle distribution (that could be fitted by a single component)
with a faster diffusion coefficient of 2763 mm
2/s corresponding to
a mean micelle radius of ,7.8 nm.
Interestingly, large deposits of non-diffusing labeled material
could be visualized by microscopic inspection of the FCS field of
view after 24 hours of incubation of C12SM LUVs with SMD
(Fig. 7C). These structures are not apparent in the untreated
sample (Fig. 7D), which continues to reveal quickly diffusing
particles. A LAURDAN GP image of the sedimented material
reveals that these structures are largely different both in shape and
in GP values (Figs. 8 B and C) from the untreated control (Fig. 8A)
and a C12SM and C12Cer-1-P (Fig. 8D) mixture in the absence of
enzyme.
When pure C12SM LUVs labeled with LAURDAN are
followed in time during enzymatic action, LAURDAN GP
increases progressively (Fig. 9), consistently with the GP measure-
ments obtained with the increasing molar fraction of C12Cer-1-P
in the premixed C12SM:C12Cer-1-P vesicles (cf. Figs. 2, 3B and
3C). At different enzyme concentrations, however, the evolution of
the GP follows very different kinetics in bulk measurements. At
high enzyme concentrations (1 and 2.5 mg/ml) the GP reaches a
maximum. This state evolves and slowly decays at 2.5 mg/ml
whereas it remains slightly more stable at 1 mg/ml although the
noise of the readings noticeably increases. When a lower enzyme
concentration is used the overall GP does not reach this maximum
reflecting a lower degree of hydrolysis in the time window of the
experiments.
Figure 3. Pre-mixed C12SM:C12Cer-1-P domains in GUVs. Representative images of domains in individual vesicles composed of 23 mol%
C12Cer-1-P visualized with (A) DiIC18 which is excluded from the C12Cer-1-P-enriched domains, B) LAURDAN intensity image at the pole of a giant
vesicle where photoselection prevents probe excitation in the more ordered domains and, C) LAURDAN GP analysis of domains in an equatorial
section showing areas of low dipolar relaxation (high GP, top histogram) and higher dipolar relaxation (lower GP, bottom histogram). Histograms
were determined opposite to each other to avoid any bias caused by photoselection. Bars are 5 mm.
doi:10.1371/journal.pone.0036003.g003
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SMD action on membranes, we performed fluorescence micros-
copy experiments using GUVs. The general observation is that
morphologically distinctive structures appear in GUVs upon
enzymatic action: many vesicles collapse, some vesicles exhibit
coexisting domains and others extrude tube-like projections. The
presence of domains can be visualized by DiIC18 exclusion
(Fig. 10A central panel) and LAURDAN GP measurements
(Fig. 10B central panel). LAURDAN GP images as well as the
observed photoselection effect of the probe show that the areas
excluding DiIC18 exhibit significantly less dipolar relaxation (more
so-like character) than the surrounding membranes ((ld -like
character). Additionally, the tubular structures that can be
observed by DiIC18 (Fig. 10A right panel) were analyzed by
measurement of the LAURDAN GP. The GP data indicate that
dipolar relaxation in these projections is lower than the control
GUVs (cf. Fig. 10B right and left panels).
The interaction between SMD and C12SM membranes
In interfacial catalysis two alternative models of interaction of
enzymes with organized substrates (membranes) have been
proposed [48]. The differences hinge upon whether the enzyme
remains adsorbed onto the supramolecular structure formed by
the substrate between catalytic events (‘‘scooting’’) or whether it
exchanges between the substrate and the surrounding aqueous
medium between catalytic events (‘‘hopping’’). To explore whether
the enzyme operates under the scooting or hopping modes we
performed kinetic studies [49] under conditions in which the
velocity of the enzyme is governed by the concentration of C12SM
present: 0.05 and 0.025 mM, which give linear slopes (Absor-
bance/s) of 4.97610
24 and 1.86610
24, respectively. Increasing
the concentration of substrate during the linear phase of the
reaction from 0.025 to 0.05 mM caused only a modest increase in
reaction velocity, from 1.86610
24 to 2.22610
24 OD/s (a 16.7%
increase). The final velocity remained well below the velocity of
the reaction measured at the higher substrate concentration,
indicating that a significant part of the enzyme does not readily
Figure 4. Kinetics of SMD activity on large unilamellar vesicles.
The main panel shows a representative trace of the kinetics of SMD
activity on LUV preparations of C12SM (red), egg SM (green) and POPC
(black) at 22uC. Inset: Specific activity of SMD on C12SM and egg SM
LUVs. The difference in specific activity is statistically significant
(P,0.0001).
doi:10.1371/journal.pone.0036003.g004
Figure 5. Dynamic Light Scattering of C12SM LUVs under the
action of SMD. Representative evolution of the size (as mean
diameter in nm) of C12SM vesicles treated with 50 ng/ml (red) and
1 mg/ml (green) SMD. The open black circles show the scattering
behavior of untreated vesicles, which was similar to control POPC
vesicles treated with SMD and C12SM vesicles treated with inactive Lb3
(not shown).
doi:10.1371/journal.pone.0036003.g005
Figure 6. Fo ¨rster resonance energy transfer (FRET) of LAUR-
DAN- and DiIC18-labeled LUVs under the action of SMD.
Separately labeled vesicles were mixed at a 1:1 ratio and treated with
SMD (1 mg/ml). Emission at the DiIC18 maximum (with excitation at
374 nm) was followed in time relative to a reference of an identical
liposome mixture without enzyme. The ordinate is the normalized ratio
of fluorescent emission of the treated over the untreated control.
doi:10.1371/journal.pone.0036003.g006
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important component of ‘‘scooting’’ in SMD action.
Protein fluorescence polarization and emission spectral shift
experiments also indicate an important degree of association
between enzyme and vesicles. Addition of LUVs to an enzyme
solution results in a marked blue shift of the protein emission
spectrum (Fig. 11), which depends on the composition of the
membranes: while the emission spectrum of SMD is slightly shifted
by non-substrate POPC vesicles with respect to the protein in
solution, the shift is much more pronounced in the presence of
C12SM membranes. A significant degree of association between
the enzyme and C12SM membranes is also apparent when
fluorescence polarization values of SMD alone or in the presence
of membranes are compared (Fig. 11 inset).
Effect of product on reaction rates
When C12SM is pre-mixed with the product at different molar
ratios and subjected to SMD, the velocity of the enzymatic
reaction is sensitive to the proportion of C12 Cer-1-P present. The
effect is not linear: using LUVs at mol fractions of 9 and 23 mol%
of Cer-1-P enzymatic activity is significantly lower than for pure
C12SM. However, at a molar ratio of 50%, enzyme activity is
comparable to pure C12SM (figure 12A).
To further explore this unexpected increase in reaction rate, we
decided to further explore the behavior of LUVs of these
Figure 7. Fluorescence correlation spectroscopy of C12SM LUVs under the action of SMD. A) Representative normalized autocorrelation
plots for the untreated vesicles (green circles), the same preparation treated with 1 mg/ml SMD (red circles) and a control with Triton X-100 (open
black circles). B) Diffusion coefficient (D2) in time calculated from fitting the autocorrelation plot for the enzyme-treated sample. The bottom panels
represent fluorescence images taken at 24 hours of C) sedimented material after enzyme treatment (1 mg/ml SMD) and D) untreated C12SM LUVs. The
images are 30 mm630 mm.
doi:10.1371/journal.pone.0036003.g007
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containing up to 23 mol% C12Cer-1-P displayed a stable scatter of
light for up to 24 hours. However, LUVs composed of 50 mol%
mixture of C12SM:C12Cer-1-P were unstable in the sense that
scattering increased at a rate roughly comparable to that of the
samples exposed to the enzyme (Fig. 12B). Additionally, this
mixture shows greater scatter at time 0 compared to the other
samples indicating spontaneous formation of different structures
shortly after extrusion. These observations preclude a direct
comparison between reaction rates in this mixture and the other
(initially stable) lipid compositions.
Effect of cholesterol
Vesicles prepared from C12SM with increasing molar fractions
of cholesterol show an increase in the LAURDAN GP values
expected for a gradual formation of a liquid ordered (lo) phase
(0.08060.002 at 9 mol%, 0.45260.019 at 23 mol% and
0.55560.017 at 50 mol%) in agreement with previous reports
[50]. At a low cholesterol level (9 mol%) enzyme activity is mostly
unaffected whereas at 23 mol% a minimum of activity (32%) is
reached. Raising cholesterol to the maximum possible incorpora-
tion increases the specific activity of the enzyme but without
reaching the value of pure C12SM (Fig. 13A). When examined in
terms of light scattering behavior (Fig. 13B), SMD action on
C12SM:cholesterol vesicles did not increase polydispersity and, in
fact, vesicle size slightly decreased relative to controls without
enzyme. This effect was more pronounced in the 50 mol%
mixture. In the absence of enzyme the size distribution of vesicles
remains stable in the time window of the experiment.
When a more complex ternary mixture of lipids composed of
DOPC:egg SM:cholesterol (2:1:1 molar ratio) is treated with SMD
an interesting effect is observed. Initially, these GUVs exhibit
domain coexistence as visualized by DiIC18 images (Fig. 14A and
left vesicle in Fig. 14B) and LAURDAN GP measurements
(Fig. 14C, left), in agreement with previously reported data for this
lipid mixture [51]. The action of SMD on these vesicles results in
the disappearance of the micron-sized domains evident in DiIC18
images (Fig. 14B, right) and LAURDAN GP measurements
(Fig. 14C, right). Enzymatic action results in an intermediate GP
value 8 hours after enzyme addition. Domains were unaffected in
the absence of active enzyme (buffer alone, not shown) or with the
same amount of inactive Lb3; Fig. 14A).
Discussion
Methodological considerations and characterization of
mixed substrate-product membranes without enzyme
Although we performed some experiments using egg SM and
C16Cer-1-P, we chose to study the effects of enzymatic conversion
in model membranes where C12SM is transformed into C12Cer-1-
P. Among the reasons for this choice are: i) the compositional
simplicity of the system, ii) that at room temperature the
membranes composed of mixtures of the substrate (C12SM) and
the product (Cer-1-P) can show ld/so phase coexistence and, iii) the
enzyme is active at this temperature. This model may approximate
some aspects of more complex membranes, where the action of
SMD on sphingomyelins may result in the production of species
with much higher melting temperature, and therefore likely to
induce the formation of more tightly packed domains than the
substrate sphingomyelin. Since C16Cer-1-P [27] and egg SM are
in the so phase at room temperature, their interest as a model for
the study of distinguishable phase differences is limited. In any
case, our experiments with C16Cer-1-P are in qualitative
agreement with previous results [27] although the transition
temperature reported is slightly lower than the one determined by
Figure 8. LAURDAN GP image of sedimented material from
C12SM LUVs treated with SMD. A) Sedimented control 100 nm
liposomes after 24 hours (without SMD) at the bottom of the slide.
Average GP value is 20.02960.129. B) Sedimented material of LUVs
treated with 1 mg/ml SMD after 24 hours at the bottom of the slide.
Average GP value is 0.22860.088. C) Same as B) but 5 mm above the
slide surface. Average GP of 0.26960.176 with areas of GP of
0.45260.124. D) Sedimented material from the 50 mol% pre-mixed
lipids without enzyme. Average GP of 20.04460.079. Fields are
19 mm619 mm.
doi:10.1371/journal.pone.0036003.g008
Figure 9. Representative kinetics of LAURDAN GP of C12SM
LUVs treated with SMD. LAURDAN-labeled C12SM LUVs were treated
with different concentrations of SMD: 100 ng/ml (green triangles), 1 mg/
ml (blue squares) and 2.5 mg/ml (red circles). The black open circles are
the same vesicles before addition of enzyme and the black crosses are
non-substrate POPC LUVs with 2.5 mg/ml SMD. The arrow indicates the
time of SMD addition.
doi:10.1371/journal.pone.0036003.g009
The Action of Sphingomyelinase D on Membranes
PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e36003us. This may be explained in part by the different sources of the
lipid used.
Pure C12Cer-1-P exhibits two endothermic transitions apparent
even after seven scans, unlike C16Cer-1-P which shows only one
stable transition. For C12Cer-1-P, LAURDAN GP measurements
above and below the lower endotherm show a persistent high GP
value. However, a significant decrease in GP, comparable to that
observed in so to ld phase transitions in glycerophospholipids, is
only apparent above the higher temperature endotherm. Interest-
ingly, while suspending C12Cer-1-P was not difficult it was not
possible to prepare LUVs by extrusion or GUVs by electroforma-
tion, suggesting that the pure component tends to exist in multiple
structures besides the bilayer.
Several observations also reveal structural heterogeneity in the
C12SM:C12Cer-1-P mixture at high C12Cer-1-P molar ratios: i)
when mixed with C12SM, C12Cer-1-P can be incorporated into
stable vesicles up to a certain relative concentration which, under
bulk equilibrium conditions, would be above 23 mol%; ii) GUVs
cannot be successfully prepared at or above 50 mol% composition;
iii) the LAURDAN GP of the sedimented material from the 50
mol% mixture shows an average GP that corresponds to pure
C12SM; iv) when the 50 mol% C12SM:C12Cer-1-P mixture is used
as the substrate in the enzyme kinetic studies, the reaction rates
recover to a level comparable to that of pure C12SM. Our
interpretation is that there is a limit to the amount of C12Cer-1-P
that mixed C12SM:C12Cer-1-P lamellar structures can accommo-
date. This stands in contrast to the ability of pure C16Cer-1-P, a
more symmetrical molecule, to form lamellar structures [27].
C12SM is a neutral lipid whereas the product of SMD action is
negatively charged. The 50 A ˚ 2 molecular area of C12SM
measured by us in Langmuir films at 30 mN/m (corresponding
to the pressure equivalence for a bilayer [43,52]) is greater than
the 38 A ˚ 2 of C12Cer-1-P, significantly altering the critical packing
parameter. This difference is solely ascribable to the different polar
head groups as the hydrophobic moiety remains the same. These
different lipid geometries and overall charges may be responsible
for a gradual transformation of membrane structure in a C12Cer-
1-P concentration-dependent manner, affecting membrane curva-
ture and driving the apparent increase in the particle size
distribution observed for the 50 mol% mixture.
Effect of membrane lateral structure on the kinetics of
SMD activity
When equal concentrations of C12SM and egg SM are
presented to the enzyme as bilayers there is a significant difference
in activity between both sphingomyelins (,60% lower for egg SM
than C12SM). At the temperature of the enzyme activity
measurements these two membranes are initially in different
phase states; C12SM is above its main phase transition temper-
ature (ld) whereas egg SM is well below its own transition
temperature (and therefore in an so phase). However, in our
experiments using mixed Triton X-100 micelles, C12SM and egg
Figure 10. Representative fluorescence microscopy images of the action of SMD on C12SM giant unilamellar vesicles. A) DiIC18-
labeled GUVs. Top left shows a typical vesicle before SMD addition and bottom left a GUV after 17 hours of incubation with inactive Lb3. The center
panel shows domain formation in several GUVs 1–3 hours after SMD addition. On the right a collapsed vesicle with extruded tubes. B) Changes in
LAURDAN GP induced by SMD. The left panel shows an untreated GUV, homogeneously fluid. The center panel shows domains of different GP value
(indicated by arrows). The right panel shows a GUV with tubular extrusions (left) and a collapsed one (right). Bars are 5 mm.
doi:10.1371/journal.pone.0036003.g010
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and 128.5613.2 mmol.min
21.mg
21, respectively), indicating that
in these conditions the chemical structure of the substrate does not
affect enzymatic catalysis. Therefore, the difference in membrane
lateral arrangement must underlie the difference in the activity of
the enzyme. This influence is additionally supported by the effect
of cholesterol, which promotes the formation of a phase with
intermediate properties (the so-called liquid ordered [lo] phase)
which also significantly affects enzyme activity in unilamellar
vesicles.
SMD action has been studied using a number of lipid species
(lysophospholipds, sphingomyelin), but the effect of lipid lateral
organization on SMD activity has not been systematically
addressed to date. For example, in a study of SMD substrate
specificity, enzymatic activity was compared between SM and a
variety of lysoglycerophospholipids [7]. It is unclear from this
study whether these very different substrate molecules exist as
monomers or how they are supramolecularly arranged (e.g. in
micelles), and the study assumes that bovine serum albumin
‘‘presents’’ the lipids to the enzyme. In our study, the only protein
present in the reactions was the enzyme itself and in these
conditions it can also hydrolyze the lysophospholipid C12LPC at a
concentration slightly above the critical micelle concentration
(CMC) with a velocity of 30% that of C12SM LUVs (data not
shown). Our observations prove that the type of supramolecular
arrangement affects SMD activity. This supramolecular organi-
zation, in turn, is governed by the chemical structure of the
individual sphingomyelin molecules although the chemical
structure by itself does not affect enzymatic activity (as the mixed
micelle kinetics show). This line of thinking may contribute to a
greater understanding of a longstanding question regarding the
toxic effects of the ubiquitous venom phospholipases, namely, why
Figure 11. Protein fluorescence spectra of SMD. The main panel
shows the normalized fluorescence emission spectrum of SMD
(excitation at 280 nm). The black trace is SMD alone, mixed with POPC
vesicles (green) and with C12SM LUVs (red). Inset: fluorescence
polarization values for the same samples. The differences in polarization
are statistically significant (P,0.003).
doi:10.1371/journal.pone.0036003.g011
Figure 12. Effect of product on relative enzyme specific activity and on vesicle size. A) Specific activity of SMD on C12SM LUVs with
increasing molar fractions of C12Cer-1-P. With the exception of pure C12SM and the 50 mol% mixture, all other differences are statistically significant
(P,0.003). B) Mean diameter in nm versus time obtained by DLS of C12SM:C12Cer-1-P LUVs: The black open circles represent pure C12SM untreated
vesicles, the green triangles represent untreated C12SM:C12Cer-1-P vesicles (23 mol%), the closed red squares are C12SM:C12Cer-1-P vesicles (50 mol%)
treated with 1 mg/ml SMD and the open red squares are the same but without enzyme.
doi:10.1371/journal.pone.0036003.g012
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hemorrhagic, neurotoxic, etc.) when almost all active phospholi-
pases can hydrolyze a wide array of phospholipids in vitro and their
potential substrates are almost universally present on the surface of
cells. Current thinking on the matter emphasizes the role of
protein determinants as the source of particular pathophysiological
effects [53–55]. The supramolecular properties of the target
membranes are not generally considered although there is
evidence that they impinge on the kinetics of enzymatic activity
in model systems [56,57] and cells [58]. In the case of SMD, it
would be of interest to compare different active recombinant
proteins in terms of sensitivity to phase state and other parameters
of the membranes containing the target lipids. This approach may
uncover functional differences of relevance to our understanding
of their toxicity and, possibly, evolution [59].
The effect of enzyme activity on the structure of C12SM
membranes
Our experiments in LUVs reveal that SMD has several effects
on C12SM membranes at room temperature. First, there is a
marked increase in the LAURDAN GP values during enzyme
action, indicating that the amount of C12Cer-1-P increases with
time. The evolution of this increment depends on enzyme
concentration and is exclusive to sphingomyelin containing
membranes (Fig. 9). Secondly, enzymatic activity causes a marked
increase in the mean size of the lipid structures, observed by DLS
and FCS. We interpret this to be the consequence, at least in part,
of membrane fusion events as revealed by probe redistribution and
supported by donor-acceptor interaction in the FRET experi-
ments. In other words, the enzyme destabilizes an initially uniform
population of LUVs and results in an increasingly more complex
system. Destabilization was also observed when premixing C12SM
with a high molar ratio of C12Cer-1-P in the absence of enzyme as
discussed above. However, the LAURDAN GP images of the
sedimented material obtained by premixing the substrate and the
Figure 13. Effect of cholesterol on relative enzyme specific activity and on vesicle size. A) Effect of cholesterol on the specific activity of
SMD. With the exception of pure C12SM and the 9 mol% mixture, all other differences are statistically significant (P,0.003). B) Mean diameter in nm
versus time obtained by DLS of C12SM:Cholesterol LUVs: The black circles represent pure C12SM vesicles with SMD, in green C12SM:cholesterol vesicles
(23 mol%) with (closed squares) and without (open squares) SMD and in red C12SM:cholesterol vesicles (50 mol%) with SMD (closed triangles) and
without (open triangles). Enzyme concentration was 1 mg/ml.
doi:10.1371/journal.pone.0036003.g013
Figure 14. Representative fluorescence images of the effect of
SMD on GUVs composed of DOPC:eggSM:cholesterol
2:1:1 mol. A) Domains in a DiIC18-labeled GUV exposed to inactive
Lb3 for 16 hours. B) Representative DiIC18-labeled GUVs before and
after treatment with SMD. C) Two LAURDAN-labeled GUVs before (left)
and after (right) exposure to SMD. Before treatment two domains are
apparent (average GP values of 0.1 and 0.5 indicated by the green and
red arrows, respectively), after SMD action the membrane becomes
uniform (average GP value of 0.3). Bars are 5 mm.
doi:10.1371/journal.pone.0036003.g014
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This suggests that the factors that determine changes in membrane
structure are different under equilibrium (premixed substrate and
product) and non-equilibrium (enzymatic hydrolysis) conditions.
Pre-mixing will generate stable mixed bilayers in both membrane
leaflets up to at least 23 mol% C12Cer-1-P. The enzyme will,
however, initially operate on the available outer leaflet only.
Product formation, given the very different molecular character-
istics (shape, charge) of the substrate and the product, probably
results in the generation of leaflets with different spontaneous
curvature thus destabilizing the bilayer and giving rise to the
multiplicity of observed structures [60]. This entails that the
evolution of the system under enzyme action cannot be fully
modeled by pre-mixing progressively greater amounts of product
with the substrate (compare Figs. 3 and 10, see above).
In bulk experiments only average quantities can be measured.
This limits interpretation of the data because information on local
structural changes induced by enzymatic change of lipid
composition is missing. This limitation is overcome by spatially
resolved measurements using fluorescence microscopy of fluores-
cently labeled GUVs. These experiments reveal that the
heterogeneity inferred from the bulk measurements is a conse-
quence of membrane morphological changes. In situ conversion
C12SM into C12Cer-1-P sequentially results in the formation of
domains with higher lipid packing, the extrusion of tubular
structures and, finally, in destabilization of the vesicular structure
of the GUV (collapse), although a few remaining vesicles fully in a
so-like phase (high LAURDAN GP) are observed. This sequence of
events would explain: i) the increase in polydispersity observed in
DLS (Fig. 5) that progressively increases the noise in the
LAURDAN GP measurements (Fig. 9) and, ii) the faster
sedimentation of material from initially monodisperse LUV
suspensions (Fig. 8). Membrane fusion was not studied in GUVs
because the yield is relatively low and the density of observable
vesicles is enough to allow visualization of events at the level of
single vesicles.
The conversion of C12SM in LUVs by high enzyme
concentration ($1 mg/ml) is almost quantitative within a few
minutes as evidenced by thin layer chromatography (data not
shown), indicating that nearly all substrate molecules are
eventually available for enzymatic hydrolysis. At lower enzyme
concentrations (50–100 ng/ml) nearly complete hydrolysis could
not be observed for up to two hours. In all experiments with
LUVs, the concentration of C12SM was kept constant at
0.25 mM. Assuming 100 nm vesicles and a molecular area per
lipid of 50 A ˚ 2, this corresponds to ,126,000 C12SM molecules per
vesicle. At a concentration of 1 mg/ml of SMD (,32 kDa), there
are on average 16 SMD molecules/LUV. Therefore, it is
reasonable to suppose that at any given moment the number of
SMD molecules acting on a single vesicle will follow some
probability distribution and, therefore, that the morphological
transformations may be heterogeneous. Coupled to the compo-
nent of ‘‘scooting’’ apparent in our experiments, the course
followed by any given vesicle would be determined largely by the
number of enzyme molecules initially attached to and acting on it.
It is also conceivable that the location of enzymes on the surface of
a given vesicle may determine the sequence, and therefore the
nature, of its morphological fate. An interesting feature of the
morphological changes observed is the extrusion of tubular
structures by some vesicles. These structures have a higher
LAURDAN GP than the untreated vesicles, suggesting that they
incorporate C12Cer-1-P. It is unclear, however, whether they are
bona fide lamellar structures. Considering the destabilization of
unilamellar vesicles by high molar fractions of C12Cer-1-P,
premixed or enzyme generated, it is reasonable to hypothesize
that this lipid favors non-lamellar structures, e.g. hexagonal phases
or tubular micelles. This is consistent with the facilitation of the
lamellar to hexagonal phase transition in Cer-1-P/ dielaidoylpho-
sphatidyl-ethanolamine mixtures [27] and the increase in
permeability in SM/cholesterol vesicles by SMD [61]. It is clear
that this phenomenon adds to the structural complexity of the
system beyond simple fusion events that would result in just larger
vesicles.
SMD activity on membranes containing Cer-1-P and
cholesterol
Progressive increase in the fraction of C12Cer-1-P up to 23
mol% in LUVs used as substrate has two effects: it reduces the
overall measured membrane dipolar relaxation (Fig. 2) and
decreases maximal initial velocity of the enzyme. Importantly, in
this range of C12Cer-1-P molar fractions, stable unilamellar
vesicles exist in the initial conditions and, just like pure C12SM
vesicles, are destabilized by the enzyme (data not shown). The
reduced dipolar relaxation of the pre-mixed samples means
progressive dehydration of the lamellar arrangement and is a
consequence of the coexistence of so domains with ld domains of
mixed composition [38]. This interpretation is consistent with a
progressive reduction of enzyme activity since a hydrolytic event
requires at least one water molecule.
The 50 mol% substrate-product mixture, however, deserves
separate consideration. Although the increase in the bulk
LAURDAN GP could be interpreted as additional incorporation
of the product into a lamellar phase, the DLS data (Fig. 12B) and
the LAURDAN GP value of the sedimented material (Fig. 8D)
show that this is not the case. There seems to be a point,
somewhere above 23 mol% C12Cer-1-P, beyond which no more of
this lipid can be incorporated into a bilayer and a multiplicity of
different structures is generated. This idea is consistent with the
incapacity to generate stable unilamellar vesicles from this mixture
and pure C12Cer-1-P. The recovery of enzyme activity is therefore
likely to be due to the action of SMD on a C12SM-rich sub-
population (such as those in Fig. 8D) available once the
unilamellar vesicle population is destabilized.
Cholesterol impacts the behavior of the system in several ways
and the response of the enzyme is also non-linear (Fig. 13A). For
this reason, we will address first the 9 and 23 mol% mixtures. In
the first instance, the initial size distribution of the vesicles is
maintained (DLS experiments in Fig. 13). The effect of 9 mol%
cholesterol on reaction rate is negligible but the rate reaches a
minimum at 23 mol%. In both cases the stability of the vesicles is
not affected by SMD. In this concentration range, LAURDAN
GP measurements before enzyme addition indicate that dipolar
relaxation decreases, consistent with the progressive transition to a
lo phase observed in glycerophospholipids [62]. These observations
also support the notion (see above) that the initial state of
hydration of the substrate modulates enzymatic activity. From the
point of view of vesicle stability, cholesterol seems to offset the
gross destabilizing effect of the product generated in situ by the
enzyme.
The non-linearity of the effect on reaction rate in the 50 mol%
C12SM:cholesterol mixture, however, is not simple to explain. For
this mixture without enzyme, the LAURDAN GP increases as
expected but the reaction rate is higher than that of the 23 mol%.
Also, the stability of the vesicles is different from that of the 50
mol% substrate:product mixture. At present, we do not under-
stand the underlying mechanism, but it is clear that there is an
increase in the availability of the substrate to SMD. Although
there is a dearth of detailed physicochemical characterizations of
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see two possibilities:
i) In bilayers of egg SM mixed with up to 50 mol% cholesterol,
vesicles incorporate only 43 mol% cholesterol [63]. However,
beyond this threshold the formation of cholesterol crystallites
is possible [64]. If this were true in the C12SM system, it raises
again the point made above that the system may not be
homogeneous anymore, i.e. generating subpopulations of
structures in which the substrate is more readily available.
ii) Parasassi et al [50] reported on particular cholesterol
concentrations at which abrupt variation of glyceropho-
spholipid-containing membrane properties can be observed
using the GP function. They proposed that the formation of
ordered molecular microdomains at critical cholesterol
concentrations, can explain the occurrence of these discon-
tinuities in the GP function [65]. These discontinuities could
reflect local heterogeneities with higher substrate availability.
However, it is not known whether this phenomenon also
occurs in C12SM membranes.
Finally, the structural consequences of SMD action on GUVs
composed of DOPC:egg SM:cholesterol is relevant to the
discussion since this mixture increases the level of initial
compositional complexity of our membrane models. The main
effect observed is that the coexistence of micron-sized lo/ld
domains is strongly affected by enzymatic generation of Cer-1-P.
In contrast to C12SM GUVs, there is no shrinking, no domain
formation and no extrusion of tubes also supporting the idea that
cholesterol offsets the structural effects of the product. Two
interpretations of the disappearance of domains are possible: i) the
domains vanish, indicating that the favored interaction between
SM and cholesterol that dictates the formation of lo domains in the
ternary mixture is strongly diminished by Cer-1-P; alternatively ii)
the size of these domains is reduced (from micro- to nanoscopic) by
an effect of the product on the domain line tension, falling below
the ,300 nm resolution of our microscope. Although the
influence of higher compositional complexity on the effects of
Cer-1-P awaits systematic study, our results show a very clear fact:
this lipid can generate microscopic domains in one context and
destroy them in another, but in neither case does its appearance
leave the supramolecular arrangements unaffected. If the enzy-
matic generation of Cer-1-P is compared to that of ceramide (the
product of sphingomyelinase C on SM) in the DOPC:egg
SM:cholesterol system, a simple change in the polar head group
results in dramatically different supramolecular behaviors. In
coexisting lo/ld systems, the in situ generation of ceramide does not
destroy microscopic domains but rather forms crystalline domains
within the lo regions [66].
Our observations show that in situ generation of Cer-1-P has
profound effects on membrane structure, suggesting that its role
may extend beyond that of a classical second messenger.
Conclusions
1) The action of SMD is dependent on the initial packing of the
model membranes containing the substrate sphingomyelin
and in situ generation of Cer-1-P has profound effects on their
supramolecular properties.
2) The effects of Cer-1-P are dependent on the composition of
the membrane. We hypothesize that SMD may have different
effects on different cellular targets.
3) The fact that SMD has a well established activity on
lysophospholipids does not mean that its action on sphingo-
myelin can be discarded in understanding loxoscelism.
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